39 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of structurally-diverse inhibitor scaffolds by high-throughput screening of a fragment library with dimethylarginine dimethylaminohydrolase.

University of Texas
Structure-based design and characterization of novel platforms for ricin and shiga toxin inhibition.

University of Texas
CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors.

University of Texas
Inhibition of monoamine oxidases A and B by simple isoquinoline alkaloids: racemic and optically active 1,2,3,4-tetrahydro-, 3,4-dihydro-, and fully aromatic isoquinolines.

University of Texas
Inhibition of human dimethylarginine dimethylaminohydrolase-1 by S-nitroso-L-homocysteine and hydrogen peroxide. Analysis, quantification, and implications for hyperhomocysteinemia.

University of Texas
Discovery of IACS-9779 and IACS-70465 as Potent Inhibitors Targeting Indoleamine 2,3-Dioxygenase 1 (IDO1) Apoenzyme.

University of Texas
1,2,3-trisubstituted cyclopropanes as conformationally restricted peptide isosteres: application to the design and synthesis of novel renin inhibitors.

University of Texas
METHIONINE ADENOSYLTRANSFERASE 2a (MAT2A) INHIBITORS AND USES THEREOF

Insilico Medicine IP
UBIQUITIN-SPECIFIC PROTEASE 1 (USP1) INHIBITOR

Simcere Zaiming Pharmaceutical Co.
ISOINDOLINONE COMPOUNDS

Monte Rosa Therapeutics
COMPOUNDS FOR THE TREATMENT OF SARS

Purdue Research Foundation
5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof

Biosplice Therapeutics
CDK inhibitors and their use as pharmaceuticals

Prelude Therapeutics
Substituted pyrrolo[1,2-a]pyrazines and pyrrolo[1,2-a][1,4]diazepines as TREX1 inhibitors

Venenum Biodesign
Therapeutic compounds and methods of use thereof

Ligature Therapeutics
Broad spectrum inhibitors of filoviruses

Microbiotix
Cycloalkyl-diamines for the treatment of inflammation

Medisynergics
Compounds that inhibit Mcl-1 protein

Amgen
Phenoxymethyl derivatives

Hoffmann-La Roche
Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides

Pfizer
Inhibitors of hepatitis C virus replication

Merck Sharp & Dohme
Tetrahydroquinoline derivatives as P2X7 receptor antagonists

Raqualia Pharma
Arylquinazolines

Merck Patent
Substituted pyrazolo[3,4-d]pyrimidines as kinase inhibitors

Principia Biopharma
Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses

Bristol-Myers Squibb
Imidazolyl kinase inhibitors and uses thereof

Dana-Farber Cancer Institute
Indole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2

Merck Sharp & Dohme
Heterocyclic inhibitors of ATR kinase

University Of Texas
Pyrazole derivatives as MALT1 inhibitors

Janssen Pharmaceutica
Triazolo-pyrimidine compounds and uses thereof

TBA
Bicyclic heterocyclic compound

Mitsubishi Tanabe Pharma
Substituted pyrazoloazepin-8-ones and their use as phosphodiesterase inhibitors

Leo Pharma
Compounds and their use for reducing uric acid levels

Acquist
Derivatives of sobetirome

Oregon Health & Science University
Sulfur-containing compounds targeting vesicular acetylcholine transporter

Washington University
3-amino-pyridines as GPBAR1 agonists

Hoffmann-La Roche
Pyrrolopyrimidine compounds and uses thereof

Hutchison Medipharma
RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist.

Roche Bioscience
Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of beta-secretase.

Merck Research Laboratories